We are interested in how different types of neurons are specified and are focusing on the cell divisions that give rise to ALM touch receptor neurons and BDU interneurons. Touch neuron-specific genes in the ALMs are activated by a MEC-3/UNC-86 heterodimer. UNC-86 is present in both the ALMs and the BDUs while MEC-3 is only present in the ALMs. PAG-3 represses
mec-3 in the BDUs and activates
mec-3 in the ALMs. After the ALM/BDU cell division, the ALMs migrate posteriorly and the BDUs migrate anteriorly. Mutations in
pag-3 cause the BDUs to express touch neuron specific genes but the ALMs and BDUs still migrate to their normal positions, suggesting that the migration and differentiation are controlled by separate mechanisms. We are interested in how the ALM and BDU cell migrations are controlled. We have identified a 104 bp DNA sequence from the
mec-3 upstream control region that, when present in the ALM touch receptor neurons in 50-100 copies, causes ALM migration defects. In animals transformed with high copy extrachromosomal arrays containing the
mec-3 upstream sequence, the ALM touch receptor neurons failed to migrate to their normal positions and sometimes migrated anteriorly. Furthermore, the PLM touch receptor neurons showed a number of axonal defects. Their axons were often short, misplaced, and some ended in a bulge that may have been a stalled growth cone. The ALM migration defect did not result from RNA interference (RNAi) because double stranded RNA that matched the
mec-3 upstream sequence did not induce ALM migration defects or PLM axonal defects. These defects did not result from nonspecific effects of carrying a transgenic array because most arrays did not cause either ALM migration defects or PLM axonal defects. In this study, the ALMs and PLMs were being visualized by GFP fluorescence. Arrays that did not contain the active sequence but had very bright GFP fluorescence did not cause the ALM or PLM defects, which shows that the defects did not result from GFP expression. Instead, the ALM migration and PLM axonal defects resulted from transgenic arrays containing many copies of a specific 104 bp DNA sequence. Transgenic arrays containing this sequence did not affect all cell migrations. The
mec-3 upstream sequence appears to be sequestering (titrating out) a specific DNA-binding factor that is required for the ALMs to migrate correctly. Because titration of this factor reversed the direction of ALM migrations, it may be part of a program that specifies both the direction and extent of ALM migrations. The titrating sequence is from the
mec-3 gene, which is a master regulator of touch receptor neuron genes, so the factor or factors that bind this sequence may also be involved in specifying the fate of the ALM touch receptor neurons. Perhaps the ALM and BDU migrations are controlled by a factor that is preferentially segregated into the ALMs and away from the BDUs during the ALM/BDU cell divisions. Cells receiving more of this factor, the ALMs, might migrate posteriorly while cells receiving less of this factor, the BDUs, might migrate anteriorly. If this hypothesis is correct, mutations in genes that produce this factor, or produce proteins that interact with this factor, should cause the ALMs to migrate anteriorly rather than posteriorly. We have isolated mutations that phenocopy the ALM migration defect and will use these mutations to identify genes and proteins involved in controlling the direction and extent of the ALM migrations.